Back to

Matthias Evers

Senior Partner, Hamburg
Helps research and development organizations increase productivity through large-scale performance transformations, innovation programs, and novel approaches for maximizing value from new assets and solutions

About Matthias

A molecular biochemist and bioinformatician by training, Matthias coleads our global work in R&D and medical functions. He has directed projects in China, Europe, India, and the United States supporting life sciences companies as they pursue innovation, drive R&D productivity, define drug and asset strategies, and pursue excellence in in core functions, from drug discovery to medical and regulatory affairs.

Matthias collaborates with executives to set innovation strategies and build the functional capabilities necessary to sustain productivity gains in R&D. When pursuing holistic performance transformations, he works to boost both speed and success by accelerating pipeline progress and making better use of available funds.

Examples of his recent client work include the following:

  • designing and supporting a pharmaceutical company’s multiyear, full scale R&D-transformation program that included a reorganization to establish an innovation culture and resulted in significant productivity gains
  • creating an ambitious strategy for digital, analytics, and experience design for a global pharmaceutical company to boost innovation and growth as well as raise productivity that led to implementation of use cases along the entire value chain
  • running a longitudinal analysis of a top ten pharmaceutical company’s five-year research and early clinical portfolio to identify predictors of success and craft a tailored capability-building program
  • designing and developing new digital solutions for innovating medical education and engagement channels as part of a newly crafted medical-affairs strategy
  • developing a strategy for worldwide therapeutic-area innovation for a provider shifting from primary care to a specialty-care and patient-stratification-focused approach
  • designing and building a virtual target-to-proof-of-concept R&D organization to navigate a full discovery and early-development pipeline with a largely externalized setup
  • leading work to drive R&D productivity for a generic-pharmaceutical business that resulted in a dramatic increase in speed, which reduced development time by almost one-third

Passionate about using science innovation to serve patients better, Matthias pursues several cross-industry activities to fuel innovation and create more science-leadership capacity. He initiated the Monastery & Minds Innovation Forum, convenes the McKinsey Medical Affairs Forum, and is a frequent speaker at high-profile events, such as the Lindau Nobel Laureate Meetings and Global Biotech Revolution’s GapSummit, which support young researchers and academia.

Published work

Ten innovations that can improve global health,” McKinsey & Company, July 2020

The Bio Revolution: Innovations transforming economies, societies, and our lives,” McKinsey Global Institute, May 2020

How growth can help Europe’s companies face the coming economic crisis,” McKinsey & Company, May 2020

How the Bio Revolution could transform the competitive landscape,” McKinsey Quarterly, May 2020

Unlocking the power of translational medicine,” McKinsey & Company, February 2020

A vision for medical affairs in 2025,” McKinsey & Company, June 2019

Real-world evidence: From activity to impact in healthcare decision making,” Digital in R&D: Customizing Patient Care, McKinsey & Company, May 2018

Medical affairs: Key imperatives for engaging and educating physicians in a digital world,” Digital in R&D: Customizing Patient Care, McKinsey & Company, March 2018

The future of drug development: Advancing clinical trial design,” Nature Reviews Drug Discovery, December 2009

Past experience

German Biotech
Associate scientist, fellow


Ruhr University Bochum
PhD, MS, biochemistry